These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 19601801

  • 1. Lectin-like oxidized low density lipoprotein receptor 1 (LOX-1) in atherogenesis: a brief review.
    Reiss AB, Anwar K, Wirkowski P.
    Curr Med Chem; 2009; 16(21):2641-52. PubMed ID: 19601801
    [Abstract] [Full Text] [Related]

  • 2. Arsenic augments the uptake of oxidized LDL by upregulating the expression of lectin-like oxidized LDL receptor in mouse aortic endothelial cells.
    Hossain E, Ota A, Karnan S, Damdindorj L, Takahashi M, Konishi Y, Konishi H, Hosokawa Y.
    Toxicol Appl Pharmacol; 2013 Dec 15; 273(3):651-8. PubMed ID: 24145059
    [Abstract] [Full Text] [Related]

  • 3. LOX-1 receptor: A potential link in atherosclerosis and cancer.
    Balzan S, Lubrano V.
    Life Sci; 2018 Apr 01; 198():79-86. PubMed ID: 29462603
    [Abstract] [Full Text] [Related]

  • 4. The lectin-like oxidized low-density-lipoprotein receptor: a pro-inflammatory factor in vascular disease.
    Dunn S, Vohra RS, Murphy JE, Homer-Vanniasinkam S, Walker JH, Ponnambalam S.
    Biochem J; 2008 Jan 15; 409(2):349-55. PubMed ID: 18092947
    [Abstract] [Full Text] [Related]

  • 5. Impact of plasma oxidized low-density lipoprotein removal on atherosclerosis.
    Ishigaki Y, Katagiri H, Gao J, Yamada T, Imai J, Uno K, Hasegawa Y, Kaneko K, Ogihara T, Ishihara H, Sato Y, Takikawa K, Nishimichi N, Matsuda H, Sawamura T, Oka Y.
    Circulation; 2008 Jul 01; 118(1):75-83. PubMed ID: 18559699
    [Abstract] [Full Text] [Related]

  • 6. Oxidized low-density lipoproteins induce tissue factor expression in T-lymphocytes via activation of lectin-like oxidized low-density lipoprotein receptor-1.
    Cimmino G, Cirillo P, Conte S, Pellegrino G, Barra G, Maresca L, Morello A, Calì G, Loffredo F, De Palma R, Arena G, Sawamura T, Ambrosio G, Golino P.
    Cardiovasc Res; 2020 May 01; 116(6):1125-1135. PubMed ID: 31504248
    [Abstract] [Full Text] [Related]

  • 7. Upregulated LOX-1 Receptor: Key Player of the Pathogenesis of Atherosclerosis.
    Singh S, Gautam AS.
    Curr Atheroscler Rep; 2019 Jul 27; 21(10):38. PubMed ID: 31350594
    [Abstract] [Full Text] [Related]

  • 8. Interplay between CRP, Atherogenic LDL, and LOX-1 and Its Potential Role in the Pathogenesis of Atherosclerosis.
    Stancel N, Chen CC, Ke LY, Chu CS, Lu J, Sawamura T, Chen CH.
    Clin Chem; 2016 Feb 27; 62(2):320-7. PubMed ID: 26607724
    [Abstract] [Full Text] [Related]

  • 9. Lectin-like Oxidized Low-Density Lipoprotein (LDL) Receptor (LOX-1): A Chameleon Receptor for Oxidized LDL.
    Zeya B, Arjuman A, Chandra NC.
    Biochemistry; 2016 Aug 16; 55(32):4437-44. PubMed ID: 27419271
    [Abstract] [Full Text] [Related]

  • 10. Role of oxidized LDL and lectin-like oxidized LDL receptor-1 in cerebral vasospasm after subarachnoid hemorrhage.
    Matsuda N, Ohkuma H, Naraoka M, Munakata A, Shimamura N, Asano K.
    J Neurosurg; 2014 Sep 16; 121(3):621-30. PubMed ID: 24949677
    [Abstract] [Full Text] [Related]

  • 11. Palmitic acid enhances lectin-like oxidized LDL receptor (LOX-1) expression and promotes uptake of oxidized LDL in macrophage cells.
    Ishiyama J, Taguchi R, Yamamoto A, Murakami K.
    Atherosclerosis; 2010 Mar 16; 209(1):118-24. PubMed ID: 19782984
    [Abstract] [Full Text] [Related]

  • 12. LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis.
    Chen M, Masaki T, Sawamura T.
    Pharmacol Ther; 2002 Jul 16; 95(1):89-100. PubMed ID: 12163130
    [Abstract] [Full Text] [Related]

  • 13. "Affimer" synthetic protein scaffolds block oxidized LDL binding to the LOX-1 scavenger receptor and inhibit ERK1/2 activation.
    Roper BWR, Tiede C, Abdul-Zani I, Cuthbert GA, Jade D, Al-Aufi A, Critchley WR, Saikia Q, Homer-Vanniasinkam S, Sawamura T, McPherson MJ, Harrison MA, Tomlinson DC, Ponnambalam S.
    J Biol Chem; 2023 Nov 16; 299(11):105325. PubMed ID: 37805141
    [Abstract] [Full Text] [Related]

  • 14. Varenicline enhances oxidized LDL uptake by increasing expression of LOX-1 and CD36 scavenger receptors through α7 nAChR in macrophages.
    Kanaoka Y, Koga M, Sugiyama K, Ohishi K, Kataoka Y, Yamauchi A.
    Toxicology; 2017 Apr 01; 380():62-71. PubMed ID: 28202387
    [Abstract] [Full Text] [Related]

  • 15. Tanshinone II-A inhibits oxidized LDL-induced LOX-1 expression in macrophages by reducing intracellular superoxide radical generation and NF-κB activation.
    Xu S, Liu Z, Huang Y, Le K, Tang F, Huang H, Ogura S, Little PJ, Shen X, Liu P.
    Transl Res; 2012 Aug 01; 160(2):114-24. PubMed ID: 22677363
    [Abstract] [Full Text] [Related]

  • 16. Ellagic acid inhibits oxidized LDL-mediated LOX-1 expression, ROS generation, and inflammation in human endothelial cells.
    Lee WJ, Ou HC, Hsu WC, Chou MM, Tseng JJ, Hsu SL, Tsai KL, Sheu WH.
    J Vasc Surg; 2010 Nov 01; 52(5):1290-300. PubMed ID: 20692795
    [Abstract] [Full Text] [Related]

  • 17. Identification of 4-hydroxy-2-nonenal-histidine adducts that serve as ligands for human lectin-like oxidized LDL receptor-1.
    Kumano-Kuramochi M, Shimozu Y, Wakita C, Ohnishi-Kameyama M, Shibata T, Matsunaga S, Takano-Ishikawa Y, Watanabe J, Goto M, Xie Q, Komba S, Uchida K, Machida S.
    Biochem J; 2012 Feb 15; 442(1):171-80. PubMed ID: 22077443
    [Abstract] [Full Text] [Related]

  • 18. Effect of IL-10 on LOX-1 expression, signalling and functional activity: an atheroprotective response.
    Arjuman A, Chandra NC.
    Diab Vasc Dis Res; 2013 Sep 15; 10(5):442-51. PubMed ID: 23811604
    [Abstract] [Full Text] [Related]

  • 19. Surface plasmon resonance study on functional significance of clustered organization of lectin-like oxidized LDL receptor (LOX-1).
    Ohki I, Amida H, Yamada R, Sugihara M, Ishigaki T, Tate S.
    Biochim Biophys Acta; 2011 Feb 15; 1814(2):345-54. PubMed ID: 21035571
    [Abstract] [Full Text] [Related]

  • 20. Cryptotanshinone, an orally bioactive herbal compound from Danshen, attenuates atherosclerosis in apolipoprotein E-deficient mice: role of lectin-like oxidized LDL receptor-1 (LOX-1).
    Liu Z, Xu S, Huang X, Wang J, Gao S, Li H, Zhou C, Ye J, Chen S, Jin ZG, Liu P.
    Br J Pharmacol; 2015 Dec 15; 172(23):5661-75. PubMed ID: 25572313
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.